Published online Oct 26, 2019. doi: 10.12998/wjcc.v7.i20.3194
Peer-review started: June 6, 2019
First decision: July 30, 2019
Revised: August 29, 2019
Accepted: September 9, 2019
Article in press: September 9, 2019
Published online: October 26, 2019
Processing time: 144 Days and 12.1 Hours
Mesenchymal tumors such as perivascular epithelioid cell neoplasm (PEComa) and inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDC sarcoma) are very uncommon neoplasms in the liver, especially in the caudate lobe. Laparoscopic resection of such tumors in the caudate lobe has not been reported.
There is no report about laparoscopic resection of the rare hepatic mesenchymal neoplasms in the caudate lobe, and we wanted to explore the feasibility of laparoscopic resection of such tumors in the caudate lobe.
To assess the safety and feasibility of laparoscopic resection of rare caudate neoplasms like PEComa and IPT-like FDC sarcoma compared with open surgery.
We analyzed the hospital stay duration, blood loss, operation time, time to removal of drainage tube, and occurrence of complications between the laparoscopic and open surgery groups.
The postoperative duration of hospital stay was significantly shorter in laparoscopic group, while the operation time, blood loss, time to removal of drainage tube, and occurrence of complications were comparable between the two groups.
Laparoscopic resection of rare mesenchymal neoplasms like PEComa and IPT-like FDC sarcoma by isolated caudate lobectomy is safe and feasible.
Our research indicates that laparoscopic caudate lobectomy is a prospective way to handle rare tumors in the caudate lobe.